Structural And Functional Networks In The Human Brain: Disturbance In Disease And Influence Of Genes.
Funder
National Health and Medical Research Council
Funding Amount
$568,892.00
Summary
Professor Graeme Jackson is a Neurologist at the Austin Hospital whose research is dedicated to the problem of understanding how epilepsy occurs and devising strategies for successful treatment. He is Deputy Director and head of the epilepsy division of the Florey Neuroscience Institutes which has research dedicated advanced MR imaging systems and physics support largely dedicated to solving these problems in epilepsy. He has 170 plus papers, 10 cited over 200 times. Career citations exceed 6000 ....Professor Graeme Jackson is a Neurologist at the Austin Hospital whose research is dedicated to the problem of understanding how epilepsy occurs and devising strategies for successful treatment. He is Deputy Director and head of the epilepsy division of the Florey Neuroscience Institutes which has research dedicated advanced MR imaging systems and physics support largely dedicated to solving these problems in epilepsy. He has 170 plus papers, 10 cited over 200 times. Career citations exceed 6000.Read moreRead less
Structural Connectomes In Traumatic Brain Injury: Can Secondary Disease Progression Be Stopped And Cognitive Deficits Be Reversed?
Funder
National Health and Medical Research Council
Funding Amount
$431,000.00
Summary
Many people with traumatic brain injury (TBI) experience cognitive problems, including poor memory and concentration. TBI is often referred to as a ‘hidden disability’ because the overwhelming majority of patients with TBI show no abnormalities on standard MRI or CT scans. In my project, I will delineate the mechanisms of secondary injury in finer detail through enhanced neuroimaging techniques, resulting in new assessment and treatment modalities for individuals with TBI.
Using Diffusion MRI For Understanding The Relationship Between Memory Decline And Corticothalamic Tracts
Funder
National Health and Medical Research Council
Funding Amount
$57,578.00
Summary
Stroke populations are at a risk of dementia. Structural changes have been demonstrated to precede cognitive changes, providing a potential for early diagnosis and intervention. Magnetic resonance imaging markers of structural connectivity are powerful predictors of dementia. As a longitudinal study, this proposal has the unique advantage that I will be able to detect changes in post-stroke brain networks in the 3 years after stroke. This raises the potential for future clinical application.
Is Stroke Neurodegenerative? A Longitudinal Study Of Changes In Brain Volume And Cognition Following Stroke
Funder
National Health and Medical Research Council
Funding Amount
$290,946.00
Summary
There is no direct evidence linking Alzheimer’s Disease (AD) and stroke. It is unknown whether stroke can trigger progressive dementia in the same way as AD. In a group of stroke patients, I will measure MRI brain volume and cognition in the 5 years after stroke. These findings will be critical for identification of those patients most at risk of dementia after stroke. This may allow future early intervention for these patients, via promising AD disease-modifying therapies.
Diagnostic And Therapeutic Implications Of Whole Genome Sequencing And Phenotyping In Hereditary Spastic Paraplegia
Funder
National Health and Medical Research Council
Funding Amount
$124,676.00
Summary
Prospective cohort study investigating progression measures in patients with hereditary spastic paraplegia including clinical phenotype, severity rating scales, motor evoked potentials and diffusion tensor imaging. These measures will be correlated with genotype using whole genome sequencing and measures of economic impact from this condition.
Assessing Paraclinical Measures Of Axonal Degeneration Following Acute Optic Neuritis
Funder
National Health and Medical Research Council
Funding Amount
$367,450.00
Summary
Multiple Sclerosis (MS) is caused by immune attack on the central nervous system (CNS), resulting in loss of the insulating material that surrounds nerve cells, as well as a degree of loss of the nerve cells themselves. Several partially effective therapies are available. A hurdle in developing CNS based therapies is methods to adequately test them. This study aims to assess biomarkers that could potentially be used to measure the damage in the optic nerve, a commonly affected structure in MS.
Targeting The Complement Activation Fragment C5a To Improve The Outcome From Spinal Cord Injury
Funder
National Health and Medical Research Council
Funding Amount
$406,838.00
Summary
This project will focus on the development of a new drug that is designed to attenuate the harmful inflammatory response that follows from spinal cord injury (SCI). The experiments will determine if the therapeutic targeting of an immune receptor molecule, called C5aR, can protect compromised neural tissues after injury against harmful inflammation and degeneration whilst also explore the mechanism behind the therapeutic effect.
Outcomes Of Treatment Decisions And Prediction Of Individual Treatment Response In Multiple Sclerosis
Funder
National Health and Medical Research Council
Funding Amount
$92,358.00
Summary
Multiple sclerosis is the most common cause of neurological disability among young people. With the increasing choice of therapies, the goal of freedom from disease has become more realistic. We will use the MSBase international multiple sclerosis registry to identify optimal, individually-tailored therapeutic strategies. We will also implement volumetric magnetic resonance imaging in routine practice, thus translating a research tool into an instrument available to patients and their doctors.
The Distribution And Spread Of Motor System Dysfunction In Early Motor Neurone Disease.
Funder
National Health and Medical Research Council
Funding Amount
$107,287.00
Summary
At present, motor neurone disease remains an incurable, fatal neurodegenerative condition with few disease-modifying treatments. There is ongoing uncertainty around the mechanisms of onset and disease propagation. This research aims to clarify the onset and pathophysiological mechanisms of motor neurone disease using novel neurophysiological and neuroimaging techniques, the results of which will contribute to the search for early diagnositc markers and new treatments.